Poly(ADP-ribose) polymerase-1 is a key mediator of cisplatin-induced kidney inflammation and injury.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Free Radical Biology & Medicine

• Publication date

  2011-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.freeradbiomed.2011.08.006PMID 21884784PMCID PMC3207278
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sulforaphane, a natural constituent of broccoli, prevents cell death and inflammation in nephropathy.

  2012cited by this paper
• c-MYC Suppresses BIN1 to Release Poly(ADP-Ribose) Polymerase 1: A Mechanism by Which Cancer Cells Acquire Cisplatin Resistance

  2011cited by this paper
• PARP INHIBITORS IN ONCOLOGY: A NEW SYNTHETIC LETHAL APPROACH TO CANCER THERAPY

  2011cited by this paper
• A review of PARP inhibitors: from bench to bedside.

  2011cited by this paper
• Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury.

  2011cited by this paper
• The clinical development of inhibitors of poly(ADP-ribose) polymerase.

  2011cited by this paper
• Regulation of Kinase Cascade Activation and Heat Shock Protein Expression by Poly(ADP-ribose) Polymerase Inhibition in Doxorubicin-induced Heart Failure

  2011cited by this paper
• The poly(ADP-ribose) polymerase-1 inhibitor 3-aminobenzamide suppresses cell growth and migration, enhancing suppressive effects of cisplatin in osteosarcoma cells.

  2011cited by this paper
• PARP inhibition alleviates diabetes-induced systemic oxidative stress and neural tissue 4-hydroxynonenal adduct accumulation: correlation with peripheral nerve function.

  2011cited by this paper
• Inhibition of poly (ADP-ribose) polymerase-1 enhances doxorubicin activity against liver cancer cells.

  2011cited by this paper
• Poly(ADP-Ribose) (PAR) Binding to Apoptosis-Inducing Factor Is Critical for PAR Polymerase-1–Dependent Cell Death (Parthanatos)

  2011cited by this paper
• Therapeutic potential of poly(ADP-ribose) polymerase inhibitor AG014699 in human cancers with mutated or methylated BRCA1 or BRCA2.

  2011cited by this paper
• How to kill tumor cells with inhibitors of poly(ADP‐ribosyl)ation

  2011cited by this paper
• MYC, PARP1, and Chemoresistance: BIN There, Done That?

  2011cited by this paper
• Iniparib plus chemotherapy in metastatic triple-negative breast cancer.

  2011cited by this paper
• Novel agents and future directions for refractory breast cancer.

  2011cited by this paper
• Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy.

  2010cited by this paper
• PARP inhibition: PARP1 and beyond

  2010cited by this paper
• Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial.

  2010cited by this paper
• Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval.

  2010cited by this paper
• Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.

  2010cited by this paper
• CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model

  2010cited by this paper
• Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.

  2010cited by this paper
• Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model.

  2010cited by this paper
• Synergistic chemosensitivity of triple-negative breast cancer cell lines to poly(ADP-Ribose) polymerase inhibition, gemcitabine, and cisplatin.

  2010cited by this paper
• Poly(ADP-ribose) polymerase-1 (PARP-1) gene deficiency alleviates diabetic kidney disease.

  2010cited by this paper
• Renal dendritic cells ameliorate nephrotoxic acute kidney injury.

  2010cited by this paper
• Heme oxygenase-1 inhibits renal tubular macroautophagy in acute kidney injury.

  2010cited by this paper
• Endogenous IL-10 Attenuates Cisplatin Nephrotoxicity: Role of Dendritic Cells

  2010cited by this paper
• Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models.

  2009cited by this paper
• Transcription factor Nrf2 is protective during ischemic and nephrotoxic acute kidney injury in mice.

  2009cited by this paper
• Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.

  2009cited by this paper
• Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats.

  2009cited by this paper
• Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro.

  2009cited by this paper
• Parthanatos, a messenger of death.

  2009cited by this paper
• Functional TauT protects against acute kidney injury.

  2009cited by this paper
• 8-hydroxy-2′ -deoxyguanosine (8-OHdG): A Critical Biomarker of Oxidative Stress and Carcinogenesis

  2009cited by this paper
• PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases.

  2009cited by this paper
• Cannabidiol Attenuates Cisplatin-Induced Nephrotoxicity by Decreasing Oxidative/Nitrosative Stress, Inflammation, and Cell Death

  2008cited by this paper
• Poly(ADP‐ribose)polymerase inhibition decreases angiogenesis.

  2008cited by this paper
• Inhibition of angiogenesis by the poly(ADP-ribose) polymerase inhibitor PJ-34.

  2008cited by this paper
• The chemistry of cell signaling by reactive oxygen and nitrogen species and 4-hydroxynonenal.

  2008cited by this paper
• Cisplatin nephrotoxicity: mechanisms and renoprotective strategies.

  2008cited by this paper
• TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity.

  2008cited by this paper
• PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy.

  2008cited by this paper
• Nitric oxide and peroxynitrite in health and disease.

  2007cited by this paper
• Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy

  2007cited by this paper
• Clinical poly(ADP-ribose) polymerase inhibitors for the treatment of cancer.

  2007cited by this paper
• Poly(ADP-Ribose) Polymerase Inhibition Reduces Atherosclerotic Plaque Size and Promotes Factors of Plaque Stability in Apolipoprotein E–Deficient Mice: Effects on Macrophage Recruitment, Nuclear Factor-&kgr;B Nuclear Translocation, and Foam Cell Death

  2007cited by this paper
• Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis.

  2007cited by this paper
• Peroxynitrite: biochemistry, pathophysiology and development of therapeutics

  2007cited by this paper
• Poly(ADP-ribose)polymerase inhibition decreases angiogenesis.

  2006cited by this paper
• Apoptosis-inducing factor mediates poly(ADP-ribose) (PAR) polymer-induced cell death

  2006cited by this paper
• A pathophysiologic role for T lymphocytes in murine acute cisplatin nephrotoxicity.

  2006cited by this paper
• Protective role of L-2-oxothiazolidine-4-carboxylic acid in cisplatin-induced renal injury.

  2006cited by this paper
• Roles of poly(ADP-ribose) polymerase activation in the pathogenesis of diabetes mellitus and its complications.

  2005cited by this paper
• Poly(ADP-ribose) polymerase regulates myocardial calcium handling in doxorubicin-induced heart failure.

  2005cited by this paper
• Clinical perspectives of PARP inhibitors.

  2005cited by this paper
• Poly(ADP-ribose) polymerase inhibition attenuates biventricular reperfusion injury after orthotopic heart transplantation.

  2005cited by this paper
• Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors

  2005cited by this paper
• Poly(ADP-Ribose) Polymerase Promotes Cardiac Remodeling, Contractile Failure, and Translocation of Apoptosis-Inducing Factor in a Murine Experimental Model of Aortic Banding and Heart Failure

  2005cited by this paper
• Cellular processing of platinum anticancer drugs

  2005cited by this paper
• Role of nitrosative stress and activation of poly(ADP-ribose) polymerase-1 in cardiovascular failure associated with septic and hemorrhagic shock.

  2005cited by this paper
• Cisplatin nephrotoxicity is mediated by deoxyribonuclease I.

  2005cited by this paper
• Poly(ADP-ribose) polymerase activation in the reperfused myocardium.

  2004cited by this paper
• Poly-ADP-Ribose Polymerase Inhibition Reduces Mesenteric Injury after Cardiopulmonary Bypass*

  2004cited by this paper
• Poly(ADP-Ribose) Polymerase Is Involved in the Development of Diabetic Retinopathy via Regulation of Nuclear Factor-κB

  2004cited by this paper
• Angiotensin II-Mediated Endothelial Dysfunction: Role of Poly(ADP-ribose) Polymerase Activation

  2004cited by this paper
• Introduction to serial reviews on 4-hydroxy-2-nonenal as a signaling molecule.

  2004cited by this paper
• Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB.

  2004cited by this paper
• Inflammatory cytokines in acute renal failure.

  2004cited by this paper
• NO-dependent protein nitration: a cell signaling event or an oxidative inflammatory response?

  2003cited by this paper
• Poly-ADP-ribose polymerase inhibition protects against myocardial and endothelial reperfusion injury after hypothermic cardiac arrest.

  2003cited by this paper
• Potent Metalloporphyrin Peroxynitrite Decomposition Catalyst Protects Against the Development of Doxorubicin-Induced Cardiac Dysfunction

  2003cited by this paper
• Poly(ADP-Ribose) Polymerase Inhibition Reduces Reperfusion Injury After Heart Transplantation

  2002cited by this paper
• Cancer therapy and renal injury.

  2002cited by this paper
• Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing Factor

  2002cited by this paper
• Activation of poly(ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation.

  2002cited by this paper
• TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity

  2002cited by this paper
• Pharmacologic inhibition of poly(adenosine diphosphate-ribose) polymerase may represent a novel therapeutic approach in chronic heart failure.

  2002cited by this paper
• Endothelial dysfunction in aging animals: the role of poly(ADP‐ribose) polymerase activation

  2002cited by this paper
• Myeloperoxidase, a Leukocyte-Derived Vascular NO Oxidase

  2002cited by this paper
• Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure.

  2002cited by this paper
• The Therapeutic Potential of Poly(ADP-Ribose) Polymerase Inhibitors

  2002cited by this paper
• The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes.

  2002cited by this paper
• TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity.

  2002cited by this paper
• Resistance to Acute Septic Peritonitis in Poly(ADP-ribose) Polymerase-1-Deficient Mice

  2002cited by this paper
• Poly(ADP-Ribose) Polymerase Is Activated in Subjects at Risk of Developing Type 2 Diabetes and Is Associated With Impaired Vascular Reactivity

  2002cited by this paper
• Manganese superoxide dismutase attenuates Cisplatin-induced renal injury: importance of superoxide.

  2001cited by this paper
• Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation

  2001cited by this paper
• Rapid Reversal of the Diabetic Endothelial Dysfunction by Pharmacological Inhibition of Poly(ADP-Ribose) Polymerase

  2001cited by this paper
• Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils

  1998cited by this paper
• Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury.

  1998cited by this paper
• POTENTIAL ROLE OF THE PEROXYNITRITE‐POLY(ADP‐RIBOSE) SYNTHETASE PATHWAY IN A RAT MODEL OF SEVERE HEMORRHAGIC SHOCK

  1998cited by this paper
• 3‐AMINOBENZAMIDE, AN INHIBITOR OF POLY (ADP‐RIBOSE) SYNTHETASE, IMPROVES HEMODYNAMICS AND PROLONGS SURVIVAL IN A PORCINE MODEL OF HEMORRHAGIC SHOCK

  1998cited by this paper
• Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion.

  1998cited by this paper
• Endothelial dysfunction in a rat model of endotoxic shock. Importance of the activation of poly (ADP-ribose) synthetase by peroxynitrite.

  1997cited by this paper
• Role of poly-ADP ribosyltransferase activation in the vascular contractile and energetic failure elicited by exogenous and endogenous nitric oxide and peroxynitrite.

  1996cited by this paper
• Nitrotyrosine as biomarker for reactive nitrogen species.

  1996cited by this paper
• 8-Hydroxydeoxyguanosine in DNA from TPA-stimulated human granulocytes.

  1994cited by this paper

• An Adverse Outcome Pathway for DNA adduct formation leading to kidney failure.

  2025cites this paper
• Ameliorating Effect of Triticum aestivum (WG) Against Cisplatin-Induced Nephrotoxicity: Role of Cytokines, Free Radicals and Apoptotic Cascade

  2025cites this paper
• PJ34 prevents cisplatin-induced hair cell loss via inhibition of PARP-1–AIF parthanatos

  2025cites this paper
• The interplay of mitophagy, autophagy, and apoptosis in cisplatin-induced kidney injury: involvement of ERK signaling pathway

  2024cites this paper
• Effect of human umbilical cord blood-mesenchymal stem cells on cisplatin-induced nephrotoxicity in rats

  2024cites this paper
• The structure change of polygonatum polysaccharide and the protect effect of Polygonatum crtonema Hua extracts and polysaccharide on cisplatin-induced AKI mice during nine-steam-nine-bask processing.

  2024cites this paper
• Luteolin as a Therapeutic Agent for Acute Kidney Injury: Network Pharmacology Predictions and Experimental Validation in a Mouse Model

  2024cites this paper
• Natural polysaccharides as promising reno-protective agents for the treatment of various kidney injury.

  2024cites this paper
• Cytosine–phosphate–guanine oligodeoxynucleotides alleviate radiation-induced kidney injury in cervical cancer by inhibiting DNA damage and oxidative stress through blockade of PARP1/XRCC1 axis

  2023cites this paper
• Protective effect of rosmarinic acid on the transmembrane transporter Ctr1 expression in cisplatin-treated mice

  2023cites this paper
• Calcitriol Reduces the Inflammation, Endothelial Damage and Oxidative Stress in AKI Caused by Cisplatin

  2022cites this paper
• Protective Effects of Orexin A in a Murine Model of Cisplatin-Induced Acute Kidney Injury

  2022cites this paper
• Roles of DNA damage repair and precise targeted therapy in renal cancer (Review)

  2022cites this paper
• Based on network pharmacology and molecular docking to explore the protective effect of Epimedii Folium extract on cisplatin-induced intestinal injury in mice

  2022cites this paper
• Determining the Potential of DNA Damage Response (DDR) Inhibitors in Cervical Cancer Therapy

  2022cites this paper
• Quercetin attenuates cyclophosphamide induced‐immunosuppressive indoleamine 2,3‐dioxygenase in the hippocampus and cerebral cortex of male Wister rats

  2022cites this paper
• Molecular Mechanisms of Parthanatos and Its Role in Diverse Diseases

  2022cites this paper
• Biomarkers in Primary Focal Segmental Glomerulosclerosis in Optimal Diagnostic-Therapeutic Strategy

  2022cites this paper
• Bromelain protects against cisplatin-induced ocular toxicity through mitigating oxidative stress and inflammation

  2021cites this paper
• Innovations and Emerging Therapies to Combat Renal Cell Damage: NAD+ As a Drug Target

  2021cites this paper
• Loganin Attenuates the Severity of Acute Kidney Injury Induced by Cisplatin through the Inhibition of ERK Activation in Mice

  2021cites this paper
• NAM protects against cisplatin-induced acute kidney injury by suppressing the PARP1/p53 pathway.

  2021cites this paper
• Carbamazepine-induced renal toxicity may be associated with oxidative stress and apoptosis in male rat

  2021cites this paper
• Melatonin rescues the mice brain against cisplatin-induced neurodegeneration, an insight into antioxidant and anti-inflammatory effects.

  2021cites this paper
• The Mechanism of Drug Nephrotoxicity and the Methods for Preventing Kidney Damage

  2021cites this paper
• Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations

  2021cites this paper
• The Role of PARP1 in Monocyte and Macrophage Commitment and Specification: Future Perspectives and Limitations for the Treatment of Monocyte and Macrophage Relevant Diseases with PARP Inhibitors

  2020cites this paper
• The effect of monotropein on alleviating cisplatin-induced acute kidney injury by inhibiting oxidative damage, inflammation and apoptosis.

  2020cites this paper
• Mitochondrial Metabolism in Acute Kidney Injury.

  2020cites this paper
• PARP-1-regulated TNF-α expression in the dorsal root ganglia and spinal dorsal horn contributes to the pathogenesis of neuropathic pain in rats.

  2020cites this paper
• How to Alleviate Side Effects of Anti-Neoplastic Drug Cisplatin by using Nanotechnology?

  2020cites this paper
• Role of renin blocker (Aliskiren) on Cisplatin induced-nephrotoxicity in rats

  2020cites this paper
• Methylglyoxal and D-lactate in cisplatin-induced acute kidney injury: Investigation of the potential mechanism via fluorogenic derivatization liquid chromatography-tandem mass spectrometry (FD-LC-MS/MS) proteomic analysis

  2020cites this paper
• The Predictive Role of the Biomarker Kidney Molecule-1 (KIM-1) in Acute Kidney Injury (AKI) Cisplatin-Induced Nephrotoxicity

  2019cites this paper
• Molecular mechanisms of cisplatin-induced nephrotoxicity: a balance on the knife edge between renoprotection and tumor toxicity

  2019cites this paper
• Multiple Targets of 3-Dehydroxyceanothetric Acid 2-Methyl Ester to Protect Against Cisplatin-Induced Cytotoxicity in Kidney Epithelial LLC-PK1 Cells

  2019cites this paper
• Anemoside B4 attenuates nephrotoxicity of cisplatin without reducing anti-tumor activity of cisplatin.

  2019cites this paper
• Supplementation of Saponins from Leaves of Panax quinquefolius Mitigates Cisplatin-Evoked Cardiotoxicity via Inhibiting Oxidative Stress-Associated Inflammation and Apoptosis in Mice

  2019cites this paper
• Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.

  2018cites this paper
• Morin hydrate ameliorates cisplatin‐induced ER stress, inflammation and autophagy in HEK‐293 cells and mice kidney via PARP‐1 regulation

  2018cites this paper
• 5-aminoisoquinoline improves renal function and fibrosis during recovery phase of cisplatin-induced acute kidney injury in rats

  2018cites this paper
• Cisplatin-induced oxidative stress stimulates renal Fas ligand shedding

  2018cites this paper
• Opportunities for the repurposing of PARP inhibitors for the therapy of non‐oncological diseases

  2018cites this paper
• Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders

  2018cites this paper
• Nox4 in renal diseases: An update

  2018cites this paper
• Comprehensive review on how platinum- and taxane-based chemotherapy of ovarian cancer affects biology of normal cells

  2018cites this paper
• Potential role of poly (ADP-ribose) polymerase in delayed cerebral vasospasm following subarachnoid hemorrhage in rats

  2018cites this paper
• From Apoptosis to Regulated Necrosis: An Evolving Understanding of Acute Kidney Injury

  2018cites this paper
• L-thyroxine modifies nephrotoxicity by regulating the apoptotic pathway: The possible role of CD38/ADP-ribosyl cyclase-mediated calcium mobilization

  2017cites this paper
• Metformin and low dose radiation modulates cisplatin-induced oxidative injury in rat via PPAR-γ and MAPK pathways.

  2017cites this paper
• Genipin attenuates cisplatin-induced nephrotoxicity by counteracting oxidative stress, inflammation, and apoptosis.

  2017cites this paper
• Vanadium(III)-L-cysteine protects cisplatin-induced nephropathy through activation of Nrf2/HO-1 pathway

  2016cites this paper
• Phase I Study of Veliparib (ABT-888) Combined with Cisplatin and Vinorelbine in Advanced Triple-Negative Breast Cancer and/or BRCA Mutation–Associated Breast Cancer

  2016cites this paper
• An Overview of Pathways of Regulated Necrosis in Acute Kidney Injury.

  2016cites this paper
• Parp1 protects against Aag-dependent alkylation-induced nephrotoxicity in a sex-dependent manner

  2016cites this paper
• Effect of Genipin on Cisplatin- Induced Nephrotoxicity

  2016cites this paper
• Dunnione ameliorates cisplatin ototoxicity through modulation of NAD(+) metabolism.

  2016cites this paper
• The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI‐101 prevents cisplatin‐induced nephrotoxicity

  2016cites this paper
• Targeting Cell Death Pathways for Therapeutic Intervention in Kidney Diseases.

  2016cites this paper
• Inhibition of PARP activation by enalapril is crucial for its renoprotective effect in cisplatin-induced nephrotoxicity in rats

  2016cites this paper
• Protective effects of icariin on cisplatin-induced acute renal injury in mice.

  2015cites this paper
• Poly(ADP-ribose) polymerase as a novel regulator of 17β-estradiol-induced cell growth through a control of the estrogen receptor/IGF-1 receptor/PDZK1 axis

  2015cites this paper
• Amelioration of cisplatin-induced nephrotoxicity in rats by triterpenoid saponin of Terminalia arjuna

  2015cites this paper
• PARP Enzymes are Potential Targets for Cancer Chemotherapy

  2015cites this paper
• Mitochondrial Modulation by Epigallocatechin 3-Gallate Ameliorates Cisplatin Induced Renal Injury through Decreasing Oxidative/Nitrative Stress, Inflammation and NF-kB in Mice

  2015cites this paper
• PARP-1 inhibitor sensitizes arsenic trioxide in hepatocellular carcinoma cells via abrogation of G2/M checkpoint and suppression of DNA damage repair.

  2015cites this paper
• The role of NF-κB in PARP-inhibitor-mediated sensitization and detoxification of arsenic trioxide in hepatocellular carcinoma cells.

  2015cites this paper
• Pharmacological inhibition of NADPH oxidase protects against cisplatin induced nephrotoxicity in mice by two step mechanism.

  2015cites this paper
• Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis

  2014cites this paper
• Poly (ADP‐ribose) polymerase‐1 is a key mediator of liver inflammation and fibrosis

  2014cites this paper
• Role of poly (ADP-ribose)-polymerase and its signaling pathway with renin-angiotensin aldosterone system in renal diseases

  2014cites this paper
• Moving beyond supportive care—current status of specific therapies in pediatric acute kidney injury

  2014cites this paper
• Augmentation of NAD+ by NQO1 attenuates cisplatin-mediated hearing impairment

  2014cites this paper
• Capsaicin Ameliorates Cisplatin-Induced Renal Injury through Induction of Heme Oxygenase-1

  2014cites this paper
• Matrine inhibits proliferation and induces apoptosis via BID-mediated mitochondrial pathway in esophageal cancer cells

  2014cites this paper
• Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis

  2014cites this paper
• Inflammation-related Genetic Variations and Survival for Advanced Non-Small Cell Lung Cancer Receiving First-line Chemotherapy

  2014cites this paper
• Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis

  2014cites this paper
• Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis

  2014cites this paper
• Protective Effect of Metalloporphyrins against Cisplatin-Induced Kidney Injury in Mice

  2014cites this paper
• PARP-1 Modulates Amyloid Beta Peptide-Induced Neuronal Damage

  2013cites this paper
• PARP-1: Friend or Foe of DNA Damage and Repair in Tumorigenesis?

  2013cites this paper
• PARP-1 Inhibitor, DPQ, Attenuates LPS-Induced Acute Lung Injury through Inhibiting NF-κB-Mediated Inflammatory Response

  2013cites this paper
• 4-Hydroxynonenal in the pathogenesis and progression of human diseases.

  2013cites this paper
• Poly(ADP-ribosyl)ation in carcinogenesis.

  2013cites this paper
• Therapeutic applications of PARP inhibitors: anticancer therapy and beyond.

  2013cites this paper
• Luteolin ameliorates cisplatin-induced nephrotoxicity in mice through inhibition of platinum accumulation, inflammation and apoptosis in the kidney.

  2013cites this paper
• PARP inhibitors in cancer therapy: an update

  2013cites this paper
• β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner.

  2012cites this paper
• Cisplatin Nephrotoxicity Involves Mitochondrial Injury with Impaired Tubular Mitochondrial Enzyme Activity

  2012cites this paper
• Role of poly(ADP‐ribose) polymerases in the regulation of inflammatory processes

  2012cites this paper
• Beneficial Effects of Montelukast against Cisplatin-Induced Acute Renal Damage in Rats

  2012cites this paper
• Mitochondrial-targeted antioxidants represent a promising approach for prevention of cisplatin-induced nephropathy.

  2012influential citation
• Title : Poly ( ADP-ribose ) polymerase-1 is a key mediator of liver inflammation and fibrosis

  year unknowncites this paper
• MIT Open

  year unknowncites this paper